Financing channel feed – Endpoints News

Financing channel feed

In a tough market, private biotechs pursue IPOs and buyouts at the same time

11 months ago

Chinese biotech developing semaglutide biosimilar files for Hong Kong IPO

11 months ago

With new mission in psychiatry, Autobahn raises $100M to help back Phase 2 work

11 months ago

Exclusive: RA Capital invests $35M in UK cancer biotech CellCentric

11 months ago

Neurology startup from OrbiMed collab nabs $65M in Series A

11 months ago

At Third Arc Bio, former J&J leaders raise $165M to test oncology, autoimmune biologics

11 months ago

Flagship launches AI-powered biologics biotech with $50M backing

11 months ago

OrbiMed forms biotech with assets from China-based Keymed, enlists former Biohaven exec as CEO

11 months ago

George Church spinout raises $60M for protein therapies from genomically recoded organisms

11 months ago

Artiva's IPO raises $167M to fund company's autoimmune and cancer cell therapies

11 months ago

Parker Institute for Cancer Immunotherapy invests another $125M into research

12 months ago

Exclusive: TMRW Life Sciences raises $28M Series D to upgrade storage for egg freezing

12 months ago

Thyme Care scores $480M valuation in new funding round

12 months ago

AI drug development company gets $80M backing from Pfizer, Nvidia and Thermo Fisher

12 months ago

Three months after delisting, NGM Bio is back with $122M for slimmed-down pipeline

12 months ago

Investment firm launches with $100M for bioprocessing entrepreneurs

12 months ago

Renalys raises $37.8M to take Travere's kidney disease drug into Phase 3 trial in Japan

12 months ago

Biotech industry flirts with XBI milestone as it surpasses $100

12 months ago

Scorpion raises $150M with sights on the next wave of targeted therapies

12 months ago

Bain-backed Cardurion raises $260M to fund ex-Imara drug, buy more cardio assets

12 months ago

German biotech CatalYm raises $150M to repurpose obesity target for cancer

12 months ago

Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau

12 months ago

Exclusive: Kins raises $7M to expand in-home and virtual physical therapy

12 months ago

Artiva aims for $116M in second attempt at IPO to boost NK cell therapy pipeline

12 months ago

First page Previous page 12 13 141516 17 18 Next page Last page